Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net Revenues	$ 131,829	$ 83,821	$ 355,162	$ 222,153
Operating Expenses
Cost of sales (excluding depreciation and amortization)	48,101	32,894	128,093	102,459
Research and development	11,121	7,657	24,419	17,096
Selling, general, and administrative	42,007	30,081	117,235	90,856
Depreciation and amortization	15,207	14,167	44,597	42,488
Contingent consideration fair value adjustment	(2,555)	2,476	(559)	2,134
Restructuring activities	0	1,541	1,132	4,111
Intangible asset impairment charge	0	0	0	112
Total Operating Expenses	113,881	88,816	314,917	259,256
Operating Income (Loss)	17,948	(4,995)	40,245	(37,103)
Other Expense, net
Interest expense, net	(6,398)	(7,264)	(21,194)	(20,546)
Other (expense) income, net	(39)	37	(126)	712
Income (Loss) Before Income Tax (Expense) Benefit	11,511	(12,222)	18,925	(56,937)
Income tax (expense) benefit	(1,571)	3,622	(1,301)	13,284
Net Income (Loss)	9,940	(8,600)	17,624	(43,653)
Dividends on Series A Convertible Preferred Stock	(406)	(406)	(1,219)	(1,218)
Net Income (Loss) Available to Common Shareholders	$ 9,534	$ (9,006)	$ 16,405	$ (44,871)
Basic and Diluted Income (Loss) Per Share:
Basic Income (Loss) Per Share (in dollars per share)	$ 0.46	$ (0.55)	$ 0.84	$ (2.76)
Diluted Income (Loss) Per Share (in dollars per share)	$ 0.45	$ (0.55)	$ 0.83	$ (2.76)
Basic Weighted-Average Shares Outstanding (in shares)	18,883	16,303	17,663	16,238
Diluted Weighted-Average Shares Outstanding (in shares)	19,125	16,303	17,823	16,238